Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

p38 MAPK Activation as the Basis for Corticosteroid Insensitivity in Severe Asthma

NCT00676572 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00676572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00676572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
p38 MAPK Activation as the Basis for Corticosteroid Insensitivity in Severe Asthma
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
May 31, 2008
Completion date
October 31, 2011
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma